We are live on ! Find out more
MVM

Medicxi Ventures Management Portfolio holdings

AUM $982M
1-Year Est. Return 210.17%
This Fund
S&P 500
This Quarter Est. Return
-14.28%
1 Year Est. Return
+210.17%
3 Year Est. Return
+787.54%
5 Year Est. Return
+404.19%
10 Year Est. Return
–
AUM
$400M
AUM Growth
-$60.1M
Cap. Flow
+$57M
Cap. Flow %
14.27%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AURA icon
Aura Biosciences
AURA
+$54.3M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$2.69M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$204M 51.07%
18,123,892
+200,000
+1% +$2.69M
AURA icon
2
Aura Biosciences
AURA
$725M
$51.6M 12.92%
+3,039,892
New +$54.3M
MRUS
3
DELISTED
Merus
MRUS
$50.9M 12.73%
1,600,000
– –
PCVX icon
4
Vaxcyte
PCVX
$7.81B
$44.9M 11.24%
1,887,478
– –
PHAT icon
5
Phathom Pharmaceuticals
PHAT
$708M
$40.7M 10.18%
2,067,861
– –
CMPI
6
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$4.31M 1.08%
1,501,716
– –
OBSV
7
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3.12M 0.78%
1,570,000
– –

Similar funds

BIP
Blueprint Investment Partners Greensboro, North Carolina $980M AUM 27.19% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PCM
Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $977M AUM 19.09% 1-Year Est. Return
FCM
Fortis Capital Management Bellevue, Washington $977M AUM 17.17% 1-Year Est. Return
FFS
Forge Financial Services Edmond, Oklahoma $987M AUM 14.12% 1-Year Est. Return
PCM
Polymer Capital Management New York $988M AUM 56.33% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

Medicxi Ventures Management's Q4 2021 Portfolio in Review

As of Q4 2021, Medicxi Ventures Management held 7 positions worth $400M, down 13% from $460M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Medicxi Ventures Management deployed $57M of net new capital in Q4 2021, opening 1 new position and adding to 1 existing holding. Its largest new stake was Aura Biosciences: 3,039,892 shares worth $51.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Medicxi Ventures Management's largest Q4 2021 buy was Aura Biosciences: 3,039,892 shares worth $51.6M.
  • Medicxi Ventures Management added most to Centessa Pharmaceuticals in Q4 2021, an estimated $2.69M increase.
  • Medicxi Ventures Management's ten largest holdings make up 100% of its $400M portfolio in Q4 2021.
  • Medicxi Ventures Management opened 1 new position and closed 0 in Q4 2021.
  • Medicxi Ventures Management's portfolio value fell 13% quarter-over-quarter to $400M.

Based on Medicxi Ventures Management's 13F filing for Q4 2021, filed 3 Feb 2022.